NHRI holds talks on drug that reduces weight loss pills side effects
02/22/2021 03:49 PM
Lo Leu-wei (羅履維) / Photo courtesy of the NHRI
Taipei, Feb. 22 (CNA) The National Health Research Institutes (NHRI) is currently in talks with Taiwanese companies to potentially mass produce a unique nanomaterial that has been found to reduce the side effects of anti-obesity drugs, an NHRI researcher said Monday.
Lo Leu-wei (羅履維), a member of a research team at the NHRI s Institute of Biomedical Engineering and Nanomedicine, said obesity is a disease of modern civilization, with obese people comprising 40 percent of the global population, citing World Health Organization (WHO) statistics.
Health worker shots by March: CECC
FALLING INTO PLACE: The Central Epidemic Control Center said that, based on the COVAX list, 200,000 doses of the Oxford-AstraZeneca vaccine should be arriving soon
By Jake Chung / Staff writer, with CNA
Starting next month, all 332,000 medical personnel nationwide are to have priority access to COVID-19 shots, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), who is spokesman for the Central Epidemic Control Center (CECC), said yesterday.
Based on the COVID-19 Vaccines Global Access (COVAX) list, 200,000 doses of the Oxford-AstraZeneca vaccine should arrive as early as next week, the center said.
Chuang said that about 140,000 people including central and local government officials who oversee disease prevention, personnel who have first contact with potential COVID-19 patients and Customs Administration personnel are second in line to receive the vaccine.
Taipei, Feb. 18 (CNA) A research team at National Tsing Hua University (NTHU) in northern Taiwan announced Thursday that it has developed a rapid test that can identify how well protected a vaccinated person is against COVID-19.
Molly Stevens Gets FEBS EMBO Women in Science Award 2021
Updated On February 11, 2021
Molly Stevens, Professor of Biomedical Materials and Regenerative Medicine in the Department of Materials and the Department of Bioengineering, at Imperial College London, received FEBS EMBO Women in Science Award 2021.
The award is an acknowledgement for her innovative bioengineering approach that addresses problems in regenerative medicine and biosensing. Her research results are being translated into the development of point-of-care tests for tumours and viruses such as HIV and Ebola virus. These biosensors are designed in a way to allow rapid diagnoses anywhere in the world. Stevens works closely with biomaterials and researches how materials can be used in the body to improve health and minimise suffering.